Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells von Jette, Nicholas R., Radhamani, Suraj, Arthur, Greydon, Ye, Ruiqiong, Goutam, Siddhartha, Bolyos, Anthony, Petersen, Lars F., Bose, Pinaki, Bebb, D. Gwyn, Lees-Miller, Susan P.

Volltext

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib von Wang, Chen, Jette, Nicholas, Moussienko, Daniel, Bebb, D. Gwyn, Lees-Miller, Susan P

Volltext

Development of an algorithm to identify small cell lung cancer patients in claims databases von Danese, Mark D, Balasubramanian, Akhila, Bebb, D Gwyn, Pundole, Xerxes

Volltext

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors von Meyers, Daniel E, Stukalin, Igor, Vallerand, Isabelle A, Lewinson, Ryan T, Suo, Aleksi, Dean, Michelle, North, Scott, Pabani, Aliyah, Cheng, Tina, Heng, Daniel Y C, Bebb, D Gwyn, Morris, Don G

Volltext

Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada von O’Sullivan, Dylan E., Cheung, Winson Y., Syed, Iqra A., Moldaver, Daniel, Shanahan, Mary Kate, Bebb, D. Gwyn, Sit, Christina, Brenner, Darren R., Boyne, Devon J.

Volltext

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada von Elegbede, Anifat A., Gibson, Amanda J., Fung, Andrea S., Cheung, Winson Y., Dean, Michelle L., Bebb, D. Gwyn, Pabani, Aliyah

Volltext

CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients von Fung, Andrea S, Kopciuk, Karen, Dean, Michelle L, D'Silva, Adrijana, Otsuka, Shannon, Klimowicz, Alexander, Hao, Desiree, Morris, Don, Bebb, D Gwyn

Volltext

ATM deficiency sensitizes mantle cell lymphoma cells to poly(ADP-ribose) polymerase-1 inhibitors von Williamson, Chris T, Muzik, Huong, Turhan, Ali G, Zamò, Alberto, O'Connor, Mark J, Bebb, D Gwyn, Lees-Miller, Susan P

Volltext

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer von Rudin, Charles M, Reck, Martin, Johnson, Melissa L, Blackhall, Fiona, Hann, Christine L, Yang, James Chih-Hsin, Bailis, Julie M, Bebb, Gwyn, Goldrick, Amanda, Umejiego, John, Paz-Ares, Luis

Volltext

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults von Bebb, D Gwyn, Banerji, Shantanu, Blais, Normand, Desmeules, Patrice, Gill, Sharlene, Grin, Andrea, Feilotter, Harriet, Hansen, Aaron R, Hyrcza, Martin, Krzyzanowska, Monika, Melosky, Barbara, Noujaim, Jonathan, Purgina, Bibiana, Ruether, Dean, Simmons, Christine E, Soulieres, Denis, Torlakovic, Emina Emilia, Tsao, Ming-Sound

Volltext

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment von Hao, Desirée, Sarfaraz, M. Omair, Farshidfar, Farshad, Bebb, D. Gwyn, Lee, Camelia Y., Card, Cynthia M., David, Marilyn, Weljie, Aalim M.

Volltext

Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and Caregivers von Bebb, D. Gwyn, Murray, Cressida, Giannopoulou, Andromachi, Felip, Enriqueta

Volltext

Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer von Ester, Manuel, Culos-Reed, S Nicole, Abdul-Razzak, Amane, Daun, Julia T, Duchek, Delaney, Francis, George, Bebb, Gwyn, Black, Jennifer, Arlain, Audra, Gillis, Chelsia, Galloway, Lyle, Capozzi, Lauren C

Volltext

Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells von Jette, Nicholas R., Radhamani, Suraj, Arthur, Greydon, Ye, Ruiqiong, Goutam, Siddhartha, Bolyos, Anthony, Petersen, Lars F., Bose, Pinaki, Bebb, D. Gwyn, Lees-Miller, Susan P.

Volltext

The CXCR4/SDF-1 Chemokine Receptor Axis: A New Target Therapeutic for Non-small Cell Lung Cancer von Otsuka, Shannon, Bebb, Gwyn

Volltext

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Datab... von Grosjean, Heidi A I, Dolter, Samantha, Meyers, Daniel E, Ding, Philip Q, Stukalin, Igor, Goutam, Siddhartha, Kong, Shiying, Chu, Quincy, Heng, Daniel Y C, Bebb, D Gwyn, Morris, Don G, Cheung, Winson Y, Pabani, Aliyah

Volltext

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors von Gibson, Amanda J.W., Box, Adrian, Dean, Michelle L., Elegbede, Anifat A., Hao, Desiree, Sangha, Randeep, Bebb, D. Gwyn

Volltext

A Comparison of Patients' and Physicians' Knowledge and Expectations Regarding Precision Oncology Tests von Dehar, Navdeep, Abedin, Tasnima, Tang, Patricia, Bebb, Gwyn, Cheung, Winson Y

Volltext

Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines von Kubota, Eiji, Williamson, Christopher T, Ye, Ruiqiong, Elegbede, Anifat, Peterson, Lars, Lees-Miller, Susan P, Bebb, D Gwyn

Volltext

Predicting PARP inhibitor sensitivity and resistance von Bebb, D. Gwyn, Lees-Miller, Susan P.

Volltext